Arrien Pharmaceuticals' Series A Round

Arrien Pharmaceuticals raised a round of funding on September 13, 2011. Investors include Hariprasad Vankayalapati.

Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways in treating neurodegenerative, cancer, inflamm…

Articles about Arrien Pharmaceuticals' Series A Round: